IP Library › Assignment 025746/0793
Patent Assignment
Reel/Frame 025746/0793

Release of Security Interest

Recorded: 2011-02-04 Pages: 14
Assignor
CREDIT SUISSE AG
Executed: 2011-01-31
Assignee
KING PHARMACEUTICALS, INC.
501 FIFTH STREET, BRISTOL, TENNESSEE, 37620
Covered Properties (69)
Multi-Fractionable Tablet Structure
Patent: 4,215,104 →
Application: 06/024,139 →
Sustained Release Tablet Containing at Least 95 Percent Theophylline
Patent: 4,465,660 →
Application: 06/451,891 →
Disubstituted Proline Derivatives,
Patent: 4,684,662 →
Application: 06/568,423 →
Racemates of Optically Active Bicyclic Imino-Alpha- Carboxylic Esters
Patent: 4,668,796 →
Application: 06/575,401 →
Process for the Preparation of N-Alkylated Dipeptides and Their Esters
Patent: 4,525,301 →
Application: 06/604,220 →
Sustained Release Tablet Containing at Least 95 Percent Theophylline
Patent: 4,547,358 →
Application: 06/616,982 →
Angiotensin-Coverting Enzyme Inhibitors
Patent: 4,587,258 →
Application: 06/635,390 →
Method for Making -2-Azabicyclo-(3.3.0)-Octane-3-Carboxylic Acids
Patent: 4,727,160 →
Application: 06/658,902 →
Method of Resolving Bicyclic Imino-Alpha-Carboxylic Acid Ester Racemates
Patent: 4,659,838 →
Application: 06/681,329 →
Optically Active Bicylic Imino-Alpha-Carboxylic Esters
Patent: 4,822,894 →
Application: 07/023,277 →
1-Carba(Dethia)-3-Hydroxy-3-Cephem Ester Crystalline and Crystalline Solvate Thereof
Patent: 4,782,144 →
Application: 07/095,721 →
Process of Preparing Proline Derivatives
Patent: 4,849,524 →
Application: 07/122,380 →
Derivatives of Bicyclic Aminocarboxylic Acids
Patent: 4,868,307 →
Application: 07/127,953 →
Process for the Preparation of N-Alkylated Dipeptides and Their Esters
Patent: 5,055,591 →
Application: 07/173,024 →
Process for the Preparation of Bicyclic Amino Carboxylic Acids, Intermediates in This Process, and Their Use
Patent: 5,011,940 →
Application: 07/214,457 →
Angiotensin-Converting Enzyme Inhibitors
Patent: 4,831,157 →
Application: 07/250,300 →
A Process for the Preparation of Cis, Endo-2- Azabicyclo-(3.3.0)-Octane-3-Carboxylic Acids
Patent: 4,879,403 →
Application: 07/267,753 →
Stabilized Medicinal Substances, a Process for the Preparation Thereof, and Stable Medicinal Formulations
Patent: 5,151,433 →
Application: 07/274,598 →
Cis, Endo-2-Azabicyclo-(3.3.0)-Octane-3-Carboxylic Acids, a Process for Their Preparation, Agents Containing These Compounds and Their Use
Patent: 5,061,722 →
Application: 07/296,513 →
Cis, Endo-2-Azabicyclo-(3.3.0)-Octane-5-Carboxylic Acids
Patent: 5,053,519 →
Application: 07/318,519 →
Photochemical Conversion of Cephalosporins, 1-Carba(1-Dethia) Cephalosporins and 1-Oxa(1-Dethia)Cephalosporins
Patent: 4,888,100 →
Application: 07/324,169 →
Intermediates for Preparing Mono-,Bi-and Tricyclic Amino Acids
Patent: 4,977,260 →
Application: 07/335,443 →
Combination of Angiotensin Converting Enzyme Inhibitors with Potassium Channel Modulators and Use Thereof in Pharmaceuticals
Patent: 4,975,453 →
Application: 07/357,822 →
Combination of Angiotensin-Converting Enzyme Inhibitors with Calcium Antagonists as Well as Their Use in Drugs
Patent: 5,098,910 →
Application: 07/358,427 →
Process and Intermediates for Chiral Epoxides
Patent: 5,097,049 →
Application: 07/518,384 →
Dmf Solvates of a Beta-Lactam Antibiotic
Patent: 4,977,257 →
Application: 07/530,140 →
Process for the Preparation of N Octahydropenta (B) Pyrrole Carboxylates
Patent: 5,068,351 →
Application: 07/560,004 →
Process for the Resolution of Racemates of Optically Active Bicyclic Imino-Alpha-Carboxylic Esters
Patent: 5,175,306 →
Application: 07/562,402 →
Method for the Treatment of Cardiac and of Vascular Hypertrophy and Hyperplasia
Patent: 5,231,083 →
Application: 07/564,618 →
Beta-Lactam Antibiotics
Patent: 5,142,039 →
Application: 07/588,381 →
Enantiomerically Selective Biocatalyzed Acylation
Patent: 5,057,607 →
Application: 07/591,586 →
Process for Preparing 4-Substituted Azetidinones
Patent: 5,106,475 →
Application: 07/598,527 →
Monohydrate and Dmf Solvates of a New Carbacephem Antibiotic
Patent: 5,091,525 →
Application: 07/601,021 →
3-Thiazolylthio Carbacephem Antibacterial Agents
Patent: 5,077,287 →
Application: 07/643,244 →
Method for the Treatment of Atherosclerosis, Thrombosis, and Peripheral Vessel Disease
Patent: 5,231,080 →
Application: 07/678,187 →
Ring-Closure Method for 1-Carbacephalosporin Six-Membered Ring
Patent: 5,089,610 →
Application: 07/691,257 →
Compounds Having a Cognition Adjuvant Action, Agents Containing Them, and the Use Thereof for the Treatment and Prophylaxis of Cognitive Dysfunctions
Patent: 5,231,084 →
Application: 07/711,719 →
Process of Enantiomeric Separation of Carbacephem Intermediates
Patent: 5,142,038 →
Application: 07/734,394 →
Intermediates to 1-Carbacephalosporins and Process for Preparation Thereof
Patent: 5,159,073 →
Application: 07/735,747 →
Novel 4-(2,3 Epoxy Propane) Azetidinones
Patent: 5,116,972 →
Application: 07/744,857 →
New Amino Protecting Group
Patent: 5,169,945 →
Application: 07/750,214 →
Process and Intermediates for Chiral Epoxides
Patent: 5,183,910 →
Application: 07/770,676 →
Usle of a Combination of Angiotensin-Converting Enzyme Inhibitor and Calcium Antagonist for the Treatment of Proteinuria
Patent: 5,236,933 →
Application: 07/798,501 →
Bicyclic Beta-Lactam Antibiotics
Patent: 5,239,068 →
Application: 07/871,376 →
Process and Intermediates for Chiral Epoxides
Patent: 5,256,807 →
Application: 07/881,913 →
Intermediates to 1-Carbacephalosporins and Process for Preparation Thereof
Patent: 5,225,553 →
Application: 07/889,221 →
New Amino Protecting Group
Patent: 5,239,069 →
Application: 07/918,196 →
Pharmaceutical Composition for the Treatment of High Blood Pressure
Patent: 5,256,687 →
Application: 07/979,390 →
Process and Intermediates for Chiral Epoxides
Patent: 5,296,615 →
Application: 08/012,109 →
Amino Protecting Group
Patent: 5,283,329 →
Application: 08/025,301 →
Use of a Combination of Angiotensin-Converting Enzyme Inhibitor and Calcium Antagonist for the Treatment of Proteinuria
Patent: 5,366,994 →
Application: 08/057,516 →
Process for Converting Loracarbef Dihydrate to Loracarbef Monohydrate
Patent: 5,374,719 →
Application: 08/071,550 →
Process for Preparing Crystalline Beta-Lactam Monohydrate
Patent: 5,352,782 →
Application: 08/071,552 →
Loracarbef Isopropanolate and a Process for Converting Loracarbef Isopropanolate to Loracarbef Monohydrate
Patent: 5,399,686 →
Application: 08/072,204 →
Loracarbef Hydrochloride C1-C3 Alcohol Solvates and Uses Thereof
Patent: 5,550,231 →
Application: 08/077,305 →
Azetidinone Intermediates to Carbacephalosporins and Process
Patent: 5,453,503 →
Application: 08/104,383 →
Method of Treating Cardiac Insufficiency Using Angiotension- Converting Enzyme Inhibitors
Patent: 5,403,856 →
Application: 08/188,745 →
Stabilized Polymer Film Coated Compounds and Stabilized Formulations in Compressed from Using Same
Patent: 5,442,008 →
Application: 08/194,634 →
Cis, Endo-2-Azabicycloalkane-3-Carboxylic Acid Derivatives
Patent: 5,550,255 →
Application: 08/202,478 →
Loracarbef Isopropanolate
Patent: 5,672,700 →
Application: 08/347,759 →
Process for Preparing Loracarbef Monohydrate
Patent: 5,580,977 →
Application: 08/396,948 →
Azetidinone Intermediates to Carbacephalosporins and Process
Patent: 5,646,275 →
Application: 08/428,613 →
Loracarbef Hydrochloride C1-C3 Alcohol Solvates and Uses Thereof
Patent: 5,578,720 →
Application: 08/444,124 →
Azetidinone Intermediates to Carbacephalosporins and Process
Patent: 5,637,692 →
Application: 08/464,480 →
Identification Test for Highly Refined Sesame Oil
Patent: 5,811,313 →
Application: 08/877,752 →
Preparations Stimulating Nail Growth
Patent: 6,007,798 →
Application: 08/930,562 →
Pharmaceutical Combination Preparation of an Inhibitor of the Sodium/Hydrogen Exchanger and a Medicament for the Treatment of Cardiovascular Diseases
Application: 09/139,385 →
Diagnostic Uses of 2-Substituted Adenosine Carboxamides
Patent: 6,368,573 →
Application: 09/440,330 →
Digital still camera system and method
Application: 60/258,484 →
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 19, 2001
From: KING PHARMACEUTICALS, INC.
To: CREDIT SUISSE FIRST BOSTON
Reel/Frame 012350/0860 →
Change of Name Nov 18, 2005
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 016793/0789 →
Security Agreement Dec 30, 2008
From: KING PHARMACEUTICALS, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0883 →
Release of Security Interest May 11, 2010
From: KING PHARMACEUTICALS, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0074 →
Release of Security Interest Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS, INC.
Reel/Frame 025737/0990 →
Release of Security Interest Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025741/0564 →